[GA21-01] Evidence on orphan drugs

Last updated 12.01.2022

Project no.:
GA21-01

Report type:
Working paper

Status:
Commission completed

Department/Division:
Drug Assessment

12.01.2022

Drugs for rare diseases should also undergo a regular benefit assessment procedure at market entry. This is shown by a current IQWiG analysis.

Press release

Extract of the working paper: Evidence on orphan drugs

EN, PDF, 243 kB, PDF

published on Jan 12, 2022
Working paper: Evidence on orphan drugs

EN, PDF, 835 kB, PDF

published on Jan 12, 2022

Contact

Press contact

+49 221 356850

presse@iqwig.de

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.